Clinical Development and Commercialization
Partnering with you at every step to help get therapies quickly to the patients who need them
Achieving approval and market access for a new or improved product that enhances patients’ lives is a monumental process and significant achievement. Designing and running clinical trials and real-world studies that build strong evidence of efficacy, safety and value is an orchestrated process, and you can trust us to deliver the highest quality every step of the way.
We are committed to reinforcing patient safety and access throughout every phase of research by partnering with pharmaceutical, biotech and medical technology companies; investigators; site staff; lab and technology vendors; patients, caregivers and their communities; regulatory authorities; and health technology assessment (HTA) bodies and payors. All play a part in delivering the quality data that can drive promising compounds forward to marketed therapies.
Years of clinical and scientific leadership
Employees across the globe
Studies in the past five years
Real-world and market access engagements in the past five years
Helping you accelerate development timelines
For patients, each day saved in the drug development process represents much more than shifting points on a timeline. Time saved means time to feel better, to share with loved ones and friends, to pursue meaningful work and to achieve personal goals. In some cases, a day saved can mean time to participate in a new clinical trial for the next medical breakthrough.
Innovations designed to minimize barriers
From optimized protocols that incorporate the patient voice to expanding the availability of off-hour appointments and patient concierge services, we listen to patients and sites and offer solutions to eliminate logistical barriers.
Digital technology and home health nurses are used to capture data where patients spend the most time: in their homes.
Commited to increasing patient diversity in clinical trials
Increasing diversity is key to the development of medical products and devices that are safer and more effective for everyone who will use them. Clinical trial participants should represent the target population of patients affected by a specific disease or condition.
We are focused on using data and technology to improve trial recruitment and increase the availability of clinical trial options to all communities.
Robust, reliable data-driven approach
Whether selecting trial sites, assessing viability of next phase success or seeking market approval, data drive insights and decision making. The ability to forecast performance is central to every step in the development process. We provide proprietary data, harness big data and employ strategic, comprehensive data assessments to more quickly guide planning and forward movement.
